Identification
A:
The retention time of the oxycodone peak in the chromatogram of the
Assay preparation corresponds to that in the chromatogram of the
Standard preparation, as obtained in the
Assay.
Test solution
Transfer a portion of powdered Tablets, equivalent to about 5 mg of oxycodone hydrochloride, to a suitable screw-capped tube, add 5 mL of chloroform, sonicate for about 30 seconds, shake for several minutes, and centrifuge. Use the clear supernatant.
Application volume:
20 µL.
Developing solvent system:
a mixture of acetone, toluene, ether, and ammonium hydroxide (6:4:1:0.3).
Procedure
Proceed as directed in the chapter. Spray with
iodoplatinate TS: the
RF value, color, and size of the principal spot obtained from the
Test solution correspond to those obtained from the
Standard solution; and no other spot is observed.
Dissolution 711
Medium:
water; 500 mL.
Apparatus 2:
50 rpm.
Time:
45 minutes.
Procedure
Determine the amount of C
18H
21NO
4·HCl dissolved by employing UV absorption at about 225 nm on filtered portions of the solution under test, suitably diluted with
Dissolution Medium, if necessary, in comparison with a Standard solution having a known concentration of
USP Oxycodone RS in 0.1 N hydrochloric acid.
Tolerances
Not less than 70% (Q) of the labeled amount of C18H21NO4·HCl is dissolved in 45 minutes.
Assay
Mobile phase
Prepare a suitable mixture of 0.01
M sodium 1-heptanesulfonate, acetonitrile, and glacial acetic acid (74:25:1). Adjust this mixture with 5 N sodium hydroxide to a pH of 3.5. Make adjustments if necessary (see
System Suitability under
Chromatography 621). Filter and degas this solution before use.
Standard preparation
Dissolve an accurately weighed quantity of
USP Oxycodone RS quantitatively in
Mobile phase to obtain a solution having a known concentration of about 0.045 mg per mL.
Assay preparation
Weigh and finely powder not less than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 5 mg of oxycodone hydrochloride, to a 100-mL volumetric flask, add about 50 mL of Mobile phase, sonicate for about 5 minutes, and shake by mechanical means for about 15 minutes. Dilute with Mobile phase to volume, and mix. Filter a portion of this mixture through a filter having a porosity of 0.5 µm or finer, and use the clear filtrate as the Assay preparation.
Chromatographic system
(see
Chromatography 621)The liquid chromatograph is equipped with a 280-nm detector and a 4.6-mm × 15-cm column that contains 5-µm packing L1. The flow rate is about 1.7 mL per minute. Chromatograph the
Standard preparation, and record the peak responses as directed for
Procedure: the tailing factor for the oxycodone peak is not more than 2.0, and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 10 µL) of the
Standard preparation and the
Assay preparation into the chromatograph, record the chromatograms, and measure the responses of the oxycodone peaks. Calculate the quantity, in mg, of oxycodone hydrochloride (C
18H
21NO
4·HCl) in the portion of Tablets taken by the formula:
(351.82 / 315.37)(100C)(rU / rS),
in which 351.82 and 315.37 are the molecular weights of oxycodone hydrochloride and oxycodone base, respectively,
C is the concentration, in mg per mL, of
USP Oxycodone RS in the
Standard preparation, and
rU and
rS are the oxycodone peak responses obtained from the
Assay preparation and the
Standard preparation, respectively.